Literature DB >> 21543488

Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus.

Matthew R Buckwalter1, Phan Thi Nga, Meriadeg Ar Gouilh, Laurence Fiette, Jean-Francois Bureau, Melissa E Laird, Julian Buchrieser, Simona Ozden, Justine Cheval, Marc Eloit, Jean-Claude Manuguerra, Antoine Gessain, Paul T Brey, Arnaud Fontanet, Matthew L Albert.   

Abstract

Theiler's murine encephalitis viruses (TMEV) are divided into two subgroups based on their neurovirulence. Persistent strains resemble Theiler's original viruses (referred to as the TO subgroup), which largely induce a subclinical polioencephalomyelitis during the acute phase of the disease and can persist in the spinal cord of susceptible animals, inducing a chronic demyelinating disease. In contrast, members of the neurovirulent subgroup cause an acute encephalitis characterized by the rapid onset of paralysis and death within days following intracranial inoculation. We report herein the characterization of a novel neurovirulent strain of TMEV, identified using pyrosequencing technology and referred to as NIHE. Complete coverage of the NIHE viral genome was obtained, and it shares <90% nucleotide sequence identity to known TMEV strains irrespective of subgroup, with the greatest sequence variability being observed in genes encoding the leader and capsid proteins. The histopathological analysis of infected brain and spinal cord demonstrate inflammatory lesions and neuronal necrosis during acute infection with no evidence of viral persistence or chronic disease. Intriguingly, genetic analysis indicates the putative expression of the L protein, considered a hallmark of strains within the persistent subgroup. Thus, the identification and characterization of a novel neurovirulent TMEV strain sharing features previously associated with both subgroups will lead to a deeper understanding of the evolution of TMEV strains and new insights into the determinants of neurovirulence.

Entities:  

Mesh:

Year:  2011        PMID: 21543488      PMCID: PMC3126553          DOI: 10.1128/JVI.00274-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins.

Authors:  Sophie Delhaye; Vincent van Pesch; Thomas Michiels
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

2.  Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Authors:  Spyridon Stavrou; Zongdi Feng; Stanley M Lemon; Raymond P Roos
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

3.  Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  W P Kong; R P Roos
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Importance of amino acid 101 within capsid protein VP1 for modulation of Theiler's virus-induced disease.

Authors:  Y Wada; M L Pierce; R S Fujinami
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

Review 5.  Differential usage of carbohydrate co-receptors influences cellular tropism of Theiler's murine encephalomyelitis virus infection of the central nervous system.

Authors:  Howard L Lipton; A S Manoj Kumar; Shannon Hertzler; Honey V Reddi
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

6.  The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production.

Authors:  V van Pesch; O van Eyll; T Michiels
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Genetic mapping of the ability of Theiler's virus to persist and demyelinate.

Authors:  A McAllister; F Tangy; C Aubert; M Brahic
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Neurovirulence determinants of genetically engineered Theiler viruses.

Authors:  J L Fu; S Stein; L Rosenstein; T Bodwell; M Routbort; B L Semler; R P Roos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

9.  The role of myelin in Theiler's virus persistence in the central nervous system.

Authors:  Jean-Pierre Roussarie; Claude Ruffié; Michel Brahic
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823

10.  SPONTANEOUS ENCEPHALOMYELITIS OF MICE, A NEW VIRUS DISEASE.

Authors:  M Theiler
Journal:  J Exp Med       Date:  1937-04-30       Impact factor: 14.307

View more
  5 in total

1.  Identical consensus sequence and conserved genomic polymorphism of hepatitis E virus during controlled interspecies transmission.

Authors:  Jerome Bouquet; Justine Cheval; Sophie Rogée; Nicole Pavio; Marc Eloit
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

2.  Next generation sequencing uncovers unexpected bacterial pathogens in ticks in western Europe.

Authors:  Muriel Vayssier-Taussat; Sara Moutailler; Lorraine Michelet; Elodie Devillers; Sarah Bonnet; Justine Cheval; Charles Hébert; Marc Eloit
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

3.  Viral Clearance and Neuroinflammation in Acute TMEV Infection Vary by Host Genetic Background.

Authors:  Koedi S Lawley; Raquel R Rech; Aracely A Perez Gomez; Laura Hopkins; Gang Han; Katia Amstalden; C Jane Welsh; Colin R Young; Yava Jones-Hall; David W Threadgill; Candice L Brinkmeyer-Langford
Journal:  Int J Mol Sci       Date:  2022-09-09       Impact factor: 6.208

4.  Detection of novel viruses in porcine fecal samples from China.

Authors:  Jie-mei Yu; Jin-song Li; Yuan-yun Ao; Zhao-jun Duan
Journal:  Virol J       Date:  2013-01-30       Impact factor: 4.099

5.  Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models.

Authors:  Osamu Kotani; Asif Naeem; Tadaki Suzuki; Naoko Iwata-Yoshikawa; Yuko Sato; Noriko Nakajima; Takushi Hosomi; Hiroyuki Tsukagoshi; Kunihisa Kozawa; Hideki Hasegawa; Fumihiro Taguchi; Hiroyuki Shimizu; Noriyo Nagata
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.